Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,275 | 134 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $480.07 | 49 | $0 (2024) |
| Lilly USA, LLC | $381.35 | 22 | $0 (2023) |
| Medtronic, Inc. | $213.02 | 9 | $0 (2024) |
| Xeris Pharmaceuticals, Inc. | $185.25 | 9 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $184.50 | 5 | $0 (2024) |
| Abbott Laboratories | $115.75 | 7 | $0 (2023) |
| Dexcom, Inc. | $114.02 | 5 | $0 (2024) |
| Insulet Corporation | $110.12 | 5 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $90.82 | 5 | $0 (2024) |
| Horizon Therapeutics plc | $56.66 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $726.71 | 43 | Novo Nordisk Inc ($137.48) |
| 2023 | $502.02 | 32 | Novo Nordisk Inc ($208.49) |
| 2022 | $608.91 | 39 | Lilly USA, LLC ($179.73) |
| 2021 | $437.03 | 20 | Lilly USA, LLC ($104.80) |
All Payment Transactions
134 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $24.43 | General |
| Category: Insulin Pump | ||||||
| 12/16/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: Diabetes | ||||||
| 12/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $9.89 | General |
| Category: Diabetes | ||||||
| 12/03/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: Cardio-renal | ||||||
| 11/26/2024 | PFIZER INC. | SOMAVERT (Drug), GENOTROPIN | Food and Beverage | In-kind items and services | $26.69 | General |
| Category: ENDOCRINE DISEASE;METABOLIC DISEASE | ||||||
| 11/25/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $6.35 | General |
| Category: Diabetes | ||||||
| 11/25/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $3.72 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Bone Health | ||||||
| 11/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $3.00 | General |
| Category: Diabetes | ||||||
| 11/07/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: DIABETES | ||||||
| 11/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $9.77 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $32.29 | General |
| Category: Oncology | ||||||
| 10/22/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $23.70 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $3.66 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $2.75 | General |
| Category: Diabetes | ||||||
| 09/19/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Endocrinology | ||||||
| 08/30/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: Endocrinology | ||||||
| 08/28/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: Cardio-renal | ||||||
| 08/27/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: Diabetes | ||||||
| 08/15/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $27.57 | General |
| Category: Insulin Pump | ||||||
| 08/08/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: Durable Pump | ||||||
| 08/06/2024 | CeQur Corporation | CeQur Simplicity (Device) | Food and Beverage | Cash or cash equivalent | $17.68 | General |
| Category: Diabetes | ||||||
| 08/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.64 | General |
| Category: Diabetes | ||||||
| 07/10/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $21.06 | General |
| Category: Insulin Pump | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 221 | 316 | $59,887 | $15,144 |
| 2022 | 5 | 167 | 235 | $47,879 | $12,973 |
| 2021 | 7 | 235 | 276 | $57,104 | $15,779 |
| 2020 | 8 | 268 | 311 | $51,832 | $13,041 |
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 120 | 193 | $41,467 | $10,700 | 25.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 16 | 18 | $5,580 | $1,615 | 28.9% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 36 | 53 | $5,300 | $1,078 | 20.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $3,516 | $923.90 | 26.3% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Facility | 2023 | 25 | 28 | $2,800 | $549.84 | 19.6% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 12 | 12 | $1,224 | $277.44 | 22.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 87 | 134 | $28,676 | $7,969 | 27.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 19 | 21 | $6,510 | $1,716 | 26.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 20 | 20 | $5,860 | $1,633 | 27.9% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 25 | 43 | $4,300 | $943.60 | 21.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 16 | 17 | $2,533 | $710.61 | 28.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 101 | 129 | $26,814 | $7,126 | 26.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 37 | 40 | $12,223 | $3,702 | 30.3% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 28 | 31 | $6,454 | $1,867 | 28.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 20 | 20 | $5,860 | $1,730 | 29.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 16 | 18 | $2,583 | $649.71 | 25.2% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 18 | 23 | $2,300 | $451.22 | 19.6% |
| G2252 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2021 | 15 | 15 | $870.00 | $252.30 | 29.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 80 | 100 | $17,800 | $4,570 | 25.7% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 42 | 50 | $12,550 | $3,502 | 27.9% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 30 | 33 | $5,874 | $1,631 | 27.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 35 | 38 | $4,408 | $1,148 | 26.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 13 | 13 | $3,809 | $968.44 | 25.4% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2020 | 13 | 20 | $2,000 | $446.01 | 22.3% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 24 | 26 | $1,479 | $419.42 | 28.4% |
About Renee Schwertfeger
Renee Schwertfeger is a Anesthesiology healthcare provider based in Morgantown, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1417031378.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Renee Schwertfeger has received a total of $2,275 in payments from pharmaceutical and medical device companies, with $726.71 received in 2024. These payments were reported across 134 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($2,275).
As a Medicare-enrolled provider, Schwertfeger has provided services to 891 Medicare beneficiaries, totaling 1,138 services with total Medicare billing of $56,937. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Practice Information
- Specialty Anesthesiology
- Other Specialties Family
- Location Morgantown, WV
- Active Since 10/25/2006
- Last Updated 12/20/2007
- Taxonomy Code 207L00000X
- Entity Type Individual
- NPI Number 1417031378
Products in Payments
- Rybelsus (Drug) $244.48
- Ozempic (Drug) $235.59
- MOUNJARO (Drug) $166.75
- GVOKE HYPOPEN (Drug) $149.02
- TZIELD (Biological) $124.99
- Omnipod (Device) $110.12
- MINIMED 780G (Device) $108.43
- TRULICITY (Drug) $91.63
- FreeStyle Libre (Device) $89.30
- TRADJENTA (Drug) $72.92
- JARDIANCE (Drug) $72.69
- DEXCOM G6 TRANSMITTER (Device) $64.25
- TEPEZZA (Drug) $56.66
- Lenvima (Drug) $55.42
- BAQSIMI (Drug) $52.78
- Dexcom G6 Transmitter (Medical Supply) $49.77
- MINIMED 770G (Device) $47.78
- SOLIQUA 100/33 (Biological) $46.86
- SOMAVERT (Drug) $39.77
- Kerendia (Drug) $38.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anesthesiology Doctors in Morgantown
Dr. David Rosen, M.d, M.D
Anesthesiology — Payments: $22,150
Skyler Mccoy
Anesthesiology — Payments: $13,425
Dr. Matthew Ellison, Md, MD
Anesthesiology — Payments: $7,260
Dr. Eric Massey, M.d, M.D
Anesthesiology — Payments: $1,984
Kelsey Bauer
Anesthesiology — Payments: $1,955
Dena Danji, Md, MD
Anesthesiology — Payments: $1,177